Randomized, Parallel Group, Double-blind Trial to Evaluate Different Dose Combinations of Lercanidipine and Enalapril in Comparison With Each Component Administered Alone and With Placebo in Patients With Essential Hypertension.

Trial Profile

Randomized, Parallel Group, Double-blind Trial to Evaluate Different Dose Combinations of Lercanidipine and Enalapril in Comparison With Each Component Administered Alone and With Placebo in Patients With Essential Hypertension.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jan 2016

At a glance

  • Drugs Enalapril (Primary) ; Lercanidipine (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms FELT
  • Sponsors Recordati
  • Most Recent Events

    • 29 Apr 2012 Results presented at the 22nd European Meeting on Hypertension.
    • 21 Apr 2012 Additional locations (Germany, Poland, Spain) added as reported by European Clinical Trials Database record.
    • 28 Apr 2011 Actual end date (April 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top